Nexsen (FRA:WG0) OCF Margin %: 0.00% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:WG0 Nexsen Ltd FRA:WG0
5 GF Score
Price €0.13
! 2 Warning Signs
View Full Analysis

What is Nexsen OCF Margin %?

Nexsen FRA:WG0 +5.56% 5 OCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates FRA:WG0 with a GF Score™ of 5/100. The stock has 2 warning signs investors should review. Among 952 Biotechnology companies, Nexsen ranks worse than 105041.91% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Nexsen's Cash Flow from Operations for the six months ended in Dec. 2025 was €-0.53 Mil. Nexsen's Revenue for the six months ended in Dec. 2025 was €0.00 Mil. Therefore, Nexsen's OCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, Nexsen's current OCF Yield % is -1.62%.

The historical rank and industry rank for Nexsen's OCF Margin % or its related term are showing as below:


FRA:WG0's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -64.565
* Ranked among companies with meaningful OCF Margin % only.

Nexsen OCF Margin % Related Terms

Nexsen OCF Margin % Historical Data

* Premium members only.

The historical data trend for Nexsen's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nexsen OCF Margin % Chart

Nexsen Annual Data
Trend Jun23 Jun24 Jun25
OCF Margin %
0.00 0.00 0.00

Nexsen Semi-Annual Data
Jun23 Jun24 Jun25 Dec25
OCF Margin % 0.00 0.00 0.00 0.00
FRA:WG0
5GF Score
Nexsen Ltd FRA:WG0
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nexsen OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Nexsen's OCF Margin for the fiscal year that ended in Jun. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=-1.81/0
= %

Nexsen's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-0.533/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Nexsen (FRA:WG0) has a OCF Margin % of 0.00% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Nexsen and its competitors. According to the industry distribution chart, Nexsen ranks #999999 out of 952 companies in the Biotechnology industry.
Is Nexsen's OCF Margin % too high?
Nexsen's current OCF Margin % is 0.00%. Based on the distribution chart, Nexsen ranks #999999 out of 952 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Nexsen has a GF Score™ of 5/100, reflecting its overall financial health beyond just this single metric.
How does Nexsen's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Nexsen ranks #999999 out of 952 companies for OCF Margin %. This places Nexsen in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Nexsen and its competitors. Nexsen's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nexsen stock overvalued right now?
Nexsen (FRA:WG0) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Nexsen's overall GF Score™ is 5/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Nexsen (FRA:WG0), the current OCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nexsen Business Description

Other Exchanges NXN:Australia
Address 4 Bridge Street, Suite 1005, Sydney, NSW, AUS, 2000
Nexsen Ltd is a nanobiotechnology company for the development of biosensing platforms for rapid, high-precision point-of-care (POC) medical diagnostics and point-of-use sensing for veterinary, agricultural and biosecurity applications. Its products include: GBS Rapid Sensor, Chronic Kidney Disease (CKD), Bovine Mastitis, Acute Kidney Injury (AKI), and Biosecurity Pathogen Tests (x2).
5GF Score

Get the complete analysis for FRA:WG0

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.13
Price